Inhibition of Bcl-XL phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis

Molecular Pharmacology

Volumn 62, Issue 4, 2002, Pages 765-771

  Kazi, Aslamuzzaman ^a   Smith, David M ^a   Zhong, Qing ^a   Ping Dou, Q ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYTOCHROME C; EPIGALLOCATECHIN GALLATE; MITOGEN ACTIVATED PROTEIN KINASE; POLYPHENOL DERIVATIVE; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TEA; WESTERN BLOTTING;

APOPTOSIS; BCL-X PROTEIN; CATECHIN; DOWN-REGULATION; FLAVONOIDS; GENE EXPRESSION; HUMANS; MALE; MITOCHONDRIA; PHENOLS; PHOSPHORYLATION; POLYMERS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TEA; TUMOR CELLS, CULTURED;

EID: 0036784080     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.4.765     Document Type: Article

References (37)

1. An B and Dou QP (1996) Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res 56:438-442.
2. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, et al. (1999) Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10:105-115.
3. Chung JY, Huang C, Meng X, Dong Z, and Yang CS (1999) Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res 59:4610-4617.
4. Chung JY, Park JO, Phyu H, Dong Z, and Yang CS (2001) Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3′-digallate. FASEB J 15:2022-2024.
5. Cross F, Roberts J, and Weintraub H (1989) Simple and complex cell cycles. Annu Rev Cell Biol 5:341-396.
6. Dang CV and Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24:68-72.
7. Demeule M, Brossard M, Page M, Gingras D, and Beliveau R (2000) Matrix metal-loproteinase inhibition by green tea catechins. Biochim Biophys Acta 1478:51-60.
8. L is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ERK cascade. J Biol Chem 275:29980-2998.
9. Fisher DE (1994) Apoptosis in cancer therapy: crossing the threshold. Cell 78:539-42.
10. Fujiki H (1999) Two stages of cancer prevention with green tea. J Cancer Res Clin Oncol 125:589-597.
11. Gao G and Dou QP (2000) N-terminal cleavage of Bax by calpain generates a potent pro-apoptotic 18 kDa-fragment that promotes Bcl-2-independent cytochrome c release and apoptotic cell death. J Cell Biochem 80:53-72.
12. Green DR and Reed JC (1998) Mitochondria and apoptosis. Science (Wash DC) 281:1309-1312.
13. Gross A, McDonnel JM, and Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899-1911.
14. Gupta S, Ahmad N, Mohan RR, Husain MM, and Mukhtar H (1999) Prostate cancer chemeprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cancer Res 59:2115-2120.
15. Harrington EA, Fanidi A, and Evan GI (1994) Oncogenes and cell death. Curr Opin Genet Dev 4:120-129.
16. Horita M, Andreu EJ, Benito A, Arbona C, Sanz C, Benet I, Prosper F, and Fernandez-Luna JL (2000) Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL. J Exp Med 191:977-984.
17. Kessel D (1994) Modes of resistance to antitumor agents. In Vivo 8:829-834.
18. Kummer JL, Rao PK, and Heidenreich KA (1997) Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J Biol Chem 272:20490-20494.
19. Liang YC, Lin-shiau SY, Chen CF and Lin JK (1997) Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem 67:55-65.
20. Liao S, Umekita Y, Guo J, Kokontis JM, and Hiipakka RA (1995) Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett 96:239-243.
21. Lin YL and Lin JK (1997) (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Mol Pharmacol 52:465-472.
22. Masuda M, Suzui M, and Weinstein IB (2001) Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 7:4220-4229.
23. Nam S, Smith DM, and Dou QP (2001) Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 276:13322-13330.
24. Nomura M, Kaji A, He Z, Ma WY, Miyamoto K, Yang CS, and Dong Z (2001) Inhibitory mechanisms of tea polyphenols on the ultraviolet B-activated phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 276:46624-46631.
25. Pardee AB (1989) G1 events and regulation of cell proliferation. Science (Wash DC) 246:603-608.
26. Poruchynsky MS, Wang EE, Rudin CM, Blagosklonny MV, and Fojo T (1998) Bcl-xL is phosphorylated in malignant cells following microtubule disruption. Cancer Res 58:3331-3338.
27. Ren F, Zhang S, Mitchell SH, Butler R, and Young CY (2000) Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells. Oncogene 19:1924-1932.
28. Ripple GH and Wilding G (1999) Drug development in prostate cancer. Semin Oncol 26:217-226.
29. Sevilla L, Zaldumbide A, Pognonec P, and Boulukos KE (2001) Transcriptional regulation of the bcl-x gene encoding the anti-apoptotic Bcl-xL protein by Ets, Rel/NFkappaB, STAT and AP1 transcription factor families. Histol Histopathol 16:595-601.
30. Smith DM, Gao G, Zhang X, Wang G, and Dou QP (2000) Regulation of tumor cell apoptotic sensitivity during the cell cycle. Int J Mol Med 6:503-507.
31. Smith DM, Wang Z, Kazi A, Li LH, Chan TH, and Dou QP (2002) Synthetic analogs of green tea polyphenols as proteasome inhibitors. Mol Med, in press.
32. Takehara T, Liu X, Fujimoto J, Friedman SL, and Takahashi H (2001) Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology 34:55-61.
33. Tang DG and Porter AT (1997) Target to apoptosis: a hopeful weapon for prostate cancer. Prostate 32:284-293.
34. Tomida A and Tsuruo T (1999) Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anticancer Drug Des 14:169-177.
35. Yang CS (1999) Tea and health. Nutrition 15:946-949.
36. Yang F, Oz HS, Barve S, de Villiers WJ, McClain CJ, and Varilek GW (2001) The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol 60:528-533.
37. L. Biochem Biophys Res Communun 277:487-493.